Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Skin Neoplasms 1 Prostatic Neoplasms 1 Nevus 1 Melanoma 1 Lung Neoplasms 1 Dysplastic Nevus Syndrome 1 Breast Neoplasms 1

Interventions

pembrolizumab 24 Nivolumab 23 aldesleukin 21 Cyclophosphamide 20 Ipilimumab 17 Interleukin-2 17 fludarabine 15 fludarabine phosphate 14 cemiplimab 12 Radiotherapy 7 Fluorouracil 7 Biopsy 7 dabrafenib 6 Surveys and Questionnaires 6 Dacarbazine 6 trametinib 5 binimetinib 5 Vemurafenib 5 Temozolomide 5 Surgical Procedures, Operative 5 Sirolimus 5 Radiation 5 Blood Specimen Collection 5 Aminolevulinic Acid 5 sonidegib 4 encorafenib 4 Photochemotherapy 4 Mohs Surgery 4 HhAntag691 4 Educational Status 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Skin Neoplasms × Genome × Clear all

NCT05446155 2024-01-23

BioMEL

Region Skane

Dysplastic Nevus Syndrome, Melanoma, Nevus, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡